Welcome
Support Centre
21 May 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Implementation of Compliance Improvement for Amblyopia Prevention
ISRCTN ISRCTN22835481
ClinicalTrials.gov identifier
Public title Implementation of Compliance Improvement for Amblyopia Prevention
Scientific title Implementation of Compliance Improvement for Amblyopia Prevention: further training course about compliance, an effective information programme and direct referral by child health care centres, primary with orthoptists in foreign and low-SES (socio-economic status) neighbourhoods
Acronym ICI-AP
Serial number at source N/A
Study hypothesis Orthoptists work more effectually by using an improved compliance enhanced programme and a training course on compliance.
Lay summary Not provided at time of registration
Ethics approval Ethics approval received from the local medical ethics committee
Study design Non-randomised, paralled armed trial
Countries of recruitment Netherlands
Disease/condition/study domain Amblyopia
Participants - inclusion criteria 1. All newly diagnosed children with an inter-ocular difference in visual acuity of more than two logarithm of the Minimum Angle of Resolution (logMAR), strabismus and/or an anisometropia or a deprivation (e.g. cataract)
2. Age: three to six years
3. Both genders
4. Children living in an area with low Socio-Economic Status (SES) in the four big cities of the Netherlands
Participants - exclusion criteria 1. Children with equal visual acuity between the eyes (less than one logMAR line of difference in visual acuity between eyes)
2. Previous treatment for amblyopia, neurological disorder, medication, other eye disorder or decreased visual acuity caused by brain damage or trauma
Anticipated start date 01/05/2006
Anticipated end date 01/05/2009
Status of trial Completed
Patient information material
Target number of participants 300
Interventions At end of year one the orthoptist will receive a three-days training course on compliance with amblyopia prevention. Strategies and techniques to reduce non-compliance are given during the training.

All children included in the first year are the control group: receive standard orthoptic care.

All children included in the second year is the intervention group: receive the improved educational cartoon story together with a calendar and reward stickers, and a one-page information sheet for the parents. The cartoon is designed as a picture story, without text and is designed from a child’s perspective.
Primary outcome measure(s) Whether the orthoptists work is effectual, based on measurements (i.e. questionnaires) at the start of the study, before and after the training course, and at the end of the second year.
Secondary outcome measure(s) The electronic occlusion measurements for compliance (actual occlusion time/prescribed occlusion time), the fraction realised Child Health Care centre referrals and the overall acuity improvement will be determined.
Sources of funding The Netherlands Organisation for Health Research and Development (Zon-MW) (The Netherlands)
Trial website
Publications 1. 2010 results in: http://www.ncbi.nlm.nih.gov/pubmed/21091336
2. 2011 results in http://www.ncbi.nlm.nih.gov/pubmed/21399941
Contact name Dr  H J  Simonsz
  Address Erasmus Medical Center Rotterdam
Department of Ophthalmology
Room Ba 104
P.O. Box 2040
  City/town Rotterdam
  Zip/Postcode 3000 CA
  Country Netherlands
  Tel +31 (0)10 408 7275/7276
  Email simonsz@compuserve.com
Sponsor Erasmus Medical Center (The Netherlands)
  Address P.O. Box 2040
  City/town Rotterdam
  Zip/Postcode 3000 CA
  Country Netherlands
  Sponsor website: http://www.erasmusmc.nl/content/englishindex.htm
Date applied 26/09/2006
Last edited 05/04/2012
Date ISRCTN assigned 26/09/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central